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Many pressing medical challenges – such as diagnosing disease, enhancing directed
stem cell differentiation, and classifying cancers – have long been hindered by limitations
in our ability to quantify proteins in single cells. Mass-spectrometry (MS) is poised to tran-
scend these limitations by developing powerful methods to routinely quantify thousands
of proteins and proteoforms across many thousands of single cells. We outline specific
technological developments and ideas that can increase the sensitivity and throughput of
single cell MS by orders of magnitude and usher in this new age. These advances will
transform medicine and ultimately contribute to understanding biological systems on an
entirely new level.
Quantifying proteins in single cells has a long history. For decades, scientists and physicians have
used antibodies, fluorescent proteins, and MALDI-TOF to identify or quantify a few different pro-
teins per cell1–5. These methods have enabled new discoveries6, clinical applications7, and even
spawned new fields, such as understanding the role of noise in gene expression8. These impressive
achievements were made based on measuring just a few different proteins per cell.
However, many pressing needs in medicine, such as diagnosing disease and enhancing directed
stem cell differentiation, as well as transformative opportunities in biology, demand qualifying
100 − 1000 fold more proteins; they demand an entirely different set of approaches and tech-
niques. Such approaches are beginning to coalesce around new ideas and emerging technologies
in MS-based proteomics that promise quantifying thousands of proteins and all their modifica-
tions (termed proteoforms) across thousands of single mammalian cells. We begin by outlining the
urgent demand and exciting opportunities for these methods since this context can best motivate
future methodological developments. Then we discuss specific technical opportunities that can
increase the sensitivity and throughput of single cell proteomics by orders of magnitude and thus
contribute to realizing its tremendous promise.
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Limitations of population-average measurements
The ability to quantify nearly complete transcriptomes and proteomes from bulk samples has been
transformative for biomedical research9–11. It has enabled unbiased screens and unexpected discov-
eries12–14. Yet comprehensive proteome measurements have been confined to samples comprised
of many cells, reflecting only the population-average. Interpreting population-average protein lev-
els is fundamentally confounded when samples consist of heterogeneous cells. The most obvious
caveat is that the population-average may not be representative for any cell. For example, proteo-
forms may have bimodally-distributed abundances within the whole heterogenous cell population.
More generally, trends within groups – within different cell types, for instance – may disappear
or even reverse when these groups are combined, as with population-average measurements. This
phenomenon is known as Simpson’s paradox15. We recently demonstrated16 the confounding ef-
fects of Simpson’s paradox in using mRNA levels as surrogates for protein levels with bulk data,
Fig. 1a. Similarly, Simpson’s paradox can confound the interpretation of population-average pro-
tein levels as illustrated in Fig. 1b. If we only consider the average levels of the ith and the jth
proteins across cell types, the proteins seem positively correlated (Fig. 1b). However, paradox-
ically, within each cell type the abundances of the ith and the jth proteins can have an inverse
relationship (Fig. 1b). Perfect measurements of cell types sorted based on a few markers cannot
resolve such phenomena; the true relationship can be observed only by measuring proteins in sin-
gle cells.
For the reasons illustrated in the examples above, measuring protein levels in tissues – both for
establishing healthy baselines and for diagnosing disease – is best done by measuring protein
abundance in single cells. The most immediate clinical applications of single cell proteomics are
the discovery of biomarkers and their diagnostic use. In the longer term, single cell proteomics can
open new frontiers in unbiased modeling, understanding, and rational control of biological systems
as we discuss below.
Single-cell proteomics opens exciting frontiers
Single cell proteomics will allow us to perform causal protein inference and create unbiased mod-
els of direct and indirect protein interactions. These exciting prospects require estimating joint
and conditional probability distributions of proteins across single cells, which in turn require many
observations of individual proteins quantified across thousands of individual single cells. Such
estimates have been obtained only for a few proteins, relying on antibodies or fluorescent pro-
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Figure 1 | Simpson’s paradox confounds the interpretation of population-average protein and
mRNA measurements (a) For a particular gene, its protein levels across tissues can be poorly predicted
by its mRNA levels, while the average protein levels can be well predicted by scaled mRNA levels16. Thus
mRNAs levels are unreliable surrogates for relative protein levels, and we need direct measurements of pro-
teins. (b) A related manifestation of Simpson’s paradox indicates that the average levels of the ith and the
jth proteins may appear positively correlated, even though they are inversely correlated within a cell-type.
Averaging across cells, even cell types sorted based on markers, will obscure the the relationship between
the ith and the jth proteins.
teins. Reliably-estimated joint distributions of proteoforms enable modeling protein-protein de-
pendencies with the empirical probabilities, without assuming a sigmoidal, linear, or any specific
relationship. Such models can infer the dependence and its causality between any two measured
proteoforms while controlling – without assumptions – for the influence of all other measured
proteoforms. Yet, these models can control only for the measured proteins. Thus, the full power
of such analysis, which can lead to causal inference, requires measuring all relevant proteoforms.
We believe that high-throughput single-cell proteomics can estimate the joint distributions among
the relevant proteforms, and in the process catalyze a transition from the population-average mea-
surements to casual inference, elucidating direct and indirect protein interactions and signaling
mechanism. Similarly, the joint distributions enable estimating the mutual information (MI) be-
tween proteins. The MI inequality states that the mutual information between a variable X , e.g., a
kinase, and its causal variable, e.g., an upstream kinase, is always larger than the mutual informa-
tion between X and another correlated but not causal variable. This allows us to determine which
protein kinases are upstream and downstream in a signaling cascade, or another similar biological
sequence of causal events. Such progress will produce models that can predict and design the
outcomes of new treatments, e.g, rationally engineer directed differentiation of stem cells into cell
types of interest. Realizing these promises requires increasing both the sensitivity and the through-
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put of of single-cell proteomics. We believe both factors can be increased by orders of magnitude
based on the suggestions outlines below.
Transformative opportunities for realizing single cell proteomics
In the foreseeable future, two types of technologies are likely to increase the number of proteins
quantified per single cell: (i) antibodies-based methods and (ii) MS-based methods. Antibody-
based methods have a long track-record of success. For many years, the binding of antibodies to
a few cellular proteins have been assayed by measuring fluorophores, transition metals and more
recently DNA sequences conjugated to the antibodies. Such methods have measured up to a few
dozen proteins per cell. Efforts are underway to increase this number while ensuring cellular per-
meability, antibody availability, binding specificity, epitope availability, and overcoming molecular
crowding limitations. In contrast to antibody-based methods, quantifying proteins in single cells
by MS is in its infancy. Yet, initial attempts have already quantified hundreds of proteins per cell
and thousands of proteins over many single cells17. Below we focus on MS-based methods as we
believe they have the potential to afford unparalleled specificity, measurement accuracy, depth of
proteome coverage and flexibility in experimental design.
So far, most single cell MS studies have used either (i) MALDI-TOF2 whose quantitative
accuracy is undermined by variable and incomplete ionization or (ii) quantitative electrospray
ionization MS methods applied to unusually large cells, i.e., human oocytes18 or frog embryos19
that exceed the size of a typical mammalian cell (∼ 15µm diameter) by orders of magnitude20.
Protein measurements in typical mammalian cells have quantified thousands of proteins in cell
lysates corresponding to hundreds of cells21, and just recently we reported a method that allows
quantifying over a thousand proteins across many single mouse stem cells17. We believe that the
field is ready to take off from this launching point, and increase the number of accurately-quantified
proteins and the number of single cells assayed by orders of magnitude.
The relatively high copy number of proteins per cell20 can support both deep proteome quan-
tification and low sampling error compared to single cell RNA-seq. So far, RNA-seq has quantified
the most molecules per cell but the accuracy of these measurements has been limited by counting
noise: since only a subset of the RNA molecules are sampled (counted), their estimated abun-
dances contain missing values and counting error due to sampling22. If we count n molecules
out of a larger pool, the Poisson distribution estimates the standard deviation of the sampling as√
n, and thus the relative error, estimated as standard deviation over mean, is
√
n/n = 1/
√
n.
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Therefore, if we sample 20% of the mRNA molecules from a relatively abundant gene and ob-
tain 4 sequences per cell, we can expect about 1/
√
4 = 50% relative error from the sampling
alone. Since cells contain over a 1000 protein molecules per mRNA molecule20, the counting er-
ror of protein sampling is likely to be smaller: For the median protein, having 50, 000 molecules
per cell, sampling even 1% of the molecules will result in about 1/
√
500 ≈ 5% sampling error.
These numbers promise deep and accurate quantification of single-cell proteomics if we can ac-
complish the opportunities discussed below. The challenges are technical – posing no conceptual
limitations – and we believe they are tractable with current and emerging ideas and technologies.
Many of these challenges and opportunities are similar for bottom-up methods (measuring pep-
tides after protease digestion) and for top-down methods (measuring undigested proteins) and we
discuss them together, although top-down proteomics faces lower sensitivity, harder multiplexing
and more challenging protein identification.
Sample preparation
Cell extraction and separation for single cell proteomics can be similar to cell extraction for other
analytical methods, i.e., single cell RNA-seq, and such methods have been reviewed extensively23.
After extraction and separation, sample preparation for single cell proteomics should ideally result
in complete cell lysis and digestion, incur minimal loss of protein, and allow high-throughput
automation for the analysis of thousands, even millions, of single cells. Standard MS sample
preparation methods use 10− 100 µl volumes; reducing these volumes to 1 µl or less will afford a
substantial reduction in protein loss and reagents used, Fig. 2a. This protein loss is primarily due
to surface adsorption, which bulk proteomics overcomes by operating near the protein or peptide
solubility limit. To mimic that approach for single cell proteomics, given the∼ 500 pg of protein in
a typical mammalian cell20, the reaction volume should be limited to nanoliters. While techniques
for surface passivation permit that volume to expand, automated precision liquid handling will
play a large role in single cell proteomics, making sample preparation robust, high-throughput,
and cost-effective at scale. Furthermore, cell lysis methods that use only MS-compatible reagents,
e.g., sonication in water17,21, can obviate cleanup and further reduce losses. Such approaches can
increase sensitivity and throughput by orders of magnitude, Fig. 2a,d.
Peptide separation
Modern MS methods sample only a fraction of each elution peak, which corresponds to 1% or
less of the ions for each peptide that the instrument could sample (Fig. 2b). This small fraction is
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Figure 2 | Transformative opportunities for improving the quantification of single-cell proteomes.
(a) Most bulk samples prepared for MS have volume of 10− 100 µl10,11,14. Reducing the volume for sample
preparation 100× to nl can significantly reduce protein losses from the walls of tubes. (b) The sharper
the separation peaks, the larger fraction of the ions can be analyzed for a fixed sampling (injection) time.
Sharper peaks can be achieved by reducing the bore of LC columns, using monolithic columns, PLOT
columns21, or capillary electrophoresis19. (c) Typically elution peaks have a full width at the base of about
60 s and about 10 − 15 s at mid-height, while ions for MS2 are sampled for mere milliseconds. These
settings are typical for bulk proteomics and result in sampling less than 1 % of the ions delivered to the
instruments. Thus, increasing the sampling time 100× can substantially increase the ions analyzed by MS,
the sensitivity, and the accuracy of quantification. While the panel displays sampling during the apex of
the peak, this cannot always be achieved for all ions. (d) Automated liquid handling and 96 / 384 well
plates can increase the consistency of sample preparation, decrease volumes to the nl range and increase
throughput. (e) Parallel accumulation and serial injection of ions can afford increased ion sampling without
reducing throughput. (f) Larger number of barcodes will increase the number cellular proteomes quantified
per run without reducing proteome coverage or ion sampling.
sufficient for the identification of peptides in bulk samples and maximizes peptide identification
per unit time. Single cell proteomics, however, can benefit from delivering the maximum number
of ions from each peptide to the MS detectors. Two simple strategies can maximize the number of
ions delivered: (i) improved peptide separation with tighter, and therefore taller, peaks, so that the
number of ions sampled per unit time is increased; (ii) sampling a greater fraction of the elution
peaks. The first strategy is technically demanding while the second one comes at the expense of
reduced throughput per unit time. Such limitations can be, at least partially, compensated by (i)
improving the separation, i.e., using specialized liquid chromatography (LC) columns21 or cap-
illary electrophoresis19 (which is particularly promising for top-down MS), or by (ii) making all
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measurements targeted to proteins of interest, which involves programming the MS instrument to
sequence specific peptides. These strategies, alone or combined, have the potential to increase the
sensitivity of single cell proteomics by 10− 100 fold, Fig. 2b,c.
Parallel ion accumulation
Data Dependent Acquisition (DDA) with current MS hardware operates by selecting specific ions
and fragmenting them for identification and quantification. The ions are serially accumulated and
serially analyzed. This strategy is efficient when accumulation times are short. In bulk samples,
ions are abundant enough so that sampling them for a very short time results in reliable identifi-
cation and quantification. However, single-cell MS ideally should sample a large fraction of the
ions, which requires accumulating ions over longer periods of time. If ion accumulation is serial,
longer accumulation increases sensitivity but at the expense of fewer quantified peptides per unit
time. This trade-off can be resolved by accumulating ions in parallel, so that we gain sensitivity
without losing throughput. The most obvious way to accomplish parallel accumulation and par-
allel injections is by using Data Independent Acquisition (DIA). Since DIA does not allow direct
quantification from the reporter ions of isobaric tags, we can adapt it to use the complement ions
that remain bound to peptide fragments. Parallel accumulation with serial injection can be ac-
complished by using additional accumulation traps built into the MS instrument that allow parallel
accumulation but serial injection (Fig. 2e). Alternatively, parallel accumulation and serial injection
can be achieved by trapped ion mobility spectrometry24. For long accumulation times, and thus
sensitive MS, the increase in throughout by parallel accumulation is proportional to the number of
ions accumulated in parallel, and we expect to gain 2− 10 fold, Fig. 2e.
Higher-multiplexing for increased throughput
Achieving high chromatographic resolution and quantifying 1000s of proteins requires an hour of
LC-MS/MS time or more. Thus, to quantify the proteomes of thousands of single cells within
hours, we need to quantify many cells per LC-MS/MS run. Such multiplexing can be achieved by
isobaric chemical barcoding25. These barcodes are chemically identical, but distinguishable by MS
due to their different isotopic compositions. While there are a number of commercially-available
barcodes sets, the largest such set only allows the simultaneous analysis of eleven different sam-
ples. However, larger sets of barcodes can be synthesized and indeed many colleagues are actively
working on making multiplex tags that would allow 30 − 100 individual cells to be measured in
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parallel (Fig. 2f). In creating new barcodes for single cell proteomics, there is an opportunity to
solve an outstanding problem with the technology, coisolation: quantitative fragments from the
currently-available barcodes are not peptide specific, allowing the signal to be polluted by frag-
ments from different peptide species26. The barcode labeling chemistry would have to be changed
such that the barcode to peptide bond is much stronger or the barcodes require less energy for
fragmentation, allowing the quantification to be based on peptide-specific complement ions.
Protein identification and data analysis
While the analysis of single cell MS data can use tools developed for bulk MS, it raises specific
challenges and opportunities. One specific challenge is peptide sequencing. At very low abun-
dance, many peptides may not produce enough fragment ions to support confident identification.
One solution may be to include a carrier channel together with single-cells, each of which la-
beled with a unique tandem-mass-tag17. With this strategy, the fragment ions supporting peptide
identification are derived from peptides pooled across all samples, including the carrier channel17.
Combining this strategy with further increases in the number of distinct tandem-mass-tags will
further facilitate peptide identification and decrease the need for carrier cells. Another approach
is to use additional peptides characteristics, such as retention time or empirical spectra. These
approaches can exploit the fact that single cell proteomics data will contain multiple similar runs
that can be used, for example, for making spectral libraries. As we discussed already, quantify-
ing 1000s of single cells in a reasonable time frame requires barcoding, which will benefit from
new computational approaches to accurately merge quantitative data sets acquired separately. If
single cell proteomes are quantified by shotgun MS, the proteins quantified in different runs will
overlap partially, with some proteins quantified across all MS runs, while others only in a subset
of the runs. This partial overlap will result in missing data, i.e., the levels of some proteins will
not be quantified in some single cells. Such missing data are pervasive with respect to single cell
RNA-seq22, and must be handled carefully in single cell proteomics to avoid artifacts.
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